Nomogram Model Based on Clinical Risk Factors and Heart Rate Variability for Predicting All-Cause Mortality in Stage 5 CKD Patients

被引:6
|
作者
Gao, Xueyan [1 ,2 ]
Wang, Jing [1 ]
Huang, Hui [3 ]
Ye, Xiaoxue [1 ]
Cui, Ying [1 ,4 ]
Ren, Wenkai [1 ,5 ]
Xu, Fangyan [1 ,6 ]
Qian, Hanyang [1 ]
Gao, Zhanhui [7 ]
Zeng, Ming [1 ]
Yang, Guang [1 ]
Huang, Yaoyu [1 ]
Tang, Shaowen [3 ]
Xing, Changying [1 ]
Wan, Huiting [1 ]
Zhang, Lina [1 ,8 ]
Chen, Huimin [1 ,9 ]
Jiang, Yao [1 ,10 ]
Zhang, Jing [1 ]
Xiao, Yujie [1 ]
Bian, Anning [1 ]
Li, Fan [1 ]
Wei, Yongyue [3 ,11 ]
Wang, Ningning [1 ]
机构
[1] Nanjing Med Univ, Jiangsu Prov Hosp, Dept Nephrol, Affiliated Hosp 1, Nanjing, Peoples R China
[2] Nanjing Med Univ, Dept Gen Med, Geriatr Hosp, Nanjing, Peoples R China
[3] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Peoples R China
[4] Yangzhou Univ, Dept Nephrol, Northern Jiangsu Peoples Hosp, Yangzhou, Peoples R China
[5] Wenzhou Med Univ, Dept Nephrol, Affiliated Dongyang Hosp, Dongyang, Peoples R China
[6] Jiaxing Univ, Dept Nephrol, Affiliated Hosp 2, Jiaxing, Peoples R China
[7] Nanjing Med Univ, BenQ Med Ctr, Dept Nephrol, Affiliated BenQ Hosp, Nanjing, Peoples R China
[8] Zhengzhou Univ, Henan Prov Peoples Hosp, Dept Nephrol, Henan Prov Key Lab Kidney Dis & Immunol,Peoples H, Zhengzhou, Peoples R China
[9] Taizhou Peoples Hosp, Dept Nephrol, Taizhou, Peoples R China
[10] Third Peoples Hosp Jingdezhen, Dept Nephrol, Jingdezhen, Peoples R China
[11] Nanjing Med Univ, China Int Cooperat Ctr Environm & Human Hlth, Nanjing, Peoples R China
基金
中国国家自然科学基金;
关键词
chronic kidney disease; circadian rhythm; heart rate; heart rate variability; all-cause mortality; nomogram model; CHRONIC KIDNEY-DISEASE; FAILURE; IMPACT; TRIAL;
D O I
10.3389/fgene.2022.872920
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Heart rate variability (HRV), reflecting circadian rhythm of heart rate, is reported to be associated with clinical outcomes in stage 5 chronic kidney disease (CKD5) patients. Whether CKD related factors combined with HRV can improve the predictive ability for their death remains uncertain. Here we evaluated the prognosis value of nomogram model based on HRV and clinical risk factors for all-cause mortality in CKD5 patients.Methods: CKD5 patients were enrolled from multicenter between 2011 and 2019 in China. HRV parameters based on 24-h Holter and clinical risk factors associated with all-cause mortality were analyzed by multivariate Cox regression. The relationships between HRV and all-cause mortality were displayed by restricted cubic spline graphs. The predictive ability of nomogram model based on clinical risk factors and HRV were evaluated for survival rate.Results: CKD5 patients included survival subgroup (n = 155) and all-cause mortality subgroup (n = 45), with the median follow-up time of 48 months. Logarithm of standard deviation of all sinus R-R intervals (lnSDNN) (4.40 +/- 0.39 vs. 4.32 +/- 0.42; p = 0.007) and logarithm of standard deviation of average NN intervals for each 5 min (lnSDANN) (4.27 +/- 0.41 vs. 4.17 +/- 0.41; p = 0.008) were significantly higher in survival subgroup than all-cause mortality subgroup. On the basis of multivariate Cox regression analysis, the lnSDNN (HR = 0.35, 95%CI: 0.17-0.73, p = 0.01) and lnSDANN (HR = 0.36, 95% CI: 0.17-0.77, p = 0.01) were associated with all-cause mortality, their relationships were negative linear. Spearman's correlation analysis showed that lnSDNN and lnSDANN were highly correlated, so we chose lnSDNN, sex, age, BMI, diabetic mellitus (DM), beta-receptor blocker, blood glucose, phosphorus and ln intact parathyroid hormone (iPTH) levels to build the nomogram model. The area under the curve (AUC) values based on lnSDNN nomogram model for predicting 3-year and 5-year survival rates were 79.44% and 81.27%, respectively.Conclusion: In CKD5 patients decreased SDNN and SDANN measured by HRV were related with their all-cause mortality, meanwhile, SDNN and SDANN were highly correlated. Nomogram model integrated SDNN and clinical risk factors are promising for evaluating their prognosis.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Sarcopenia is an independent risk factor for all-cause mortality rate in patients with diabetic foot ulcers
    Yang, Qin
    Ni, Xia
    Zhang, Yingxiao
    Zhu, Baozhen
    Zeng, Qinglian
    Yang, Chan
    Shi, Jiale
    Zhang, Chunlin
    Cai, Jiahui
    Hu, Jinbo
    Li, Qifu
    Jiang, Yingsong
    Cheng, Qingfeng
    Cheng, Chao
    FRONTIERS IN NUTRITION, 2023, 10
  • [32] All-Cause and Cardiovascular-Related Mortality in CKD Patients With and Without Heart Failure: A Population-Based Cohort Study in Kaiser Permanente Southern California
    Yu, Albert S.
    Pak, Katherine J.
    Zhou, Hui
    Shaw, Sally F.
    Shi, Jiaxiao
    Broder, Benjamin I.
    Sim, John J.
    KIDNEY MEDICINE, 2023, 5 (05)
  • [33] Serum Biomarkers of Iron Stores Are Associated with Increased Risk of All-Cause Mortality and Cardiovascular Events in Nondialysis CKD Patients, with or without Anemia
    Guedes, Murilo
    Muenz, Daniel G.
    Zee, Jarcy
    Bieber, Brian
    Stengel, Benedicte
    Massy, Ziad A.
    Mansencal, Nicolas
    Wong, Michelle M. Y.
    Charytan, David M.
    Reichel, Helmut
    Waechter, Sandra
    Pisoni, Ronald L.
    Robinson, Bruce M.
    Pecoits-Filho, Roberto
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (08): : 2020 - 2030
  • [34] Role of Fracture Risk Assessment Tool and Bone Turnover Markers in Predicting All-Cause and Cardiovascular Mortality in Hemodialysis Patients
    Wu, Pei-Yu
    Chen, Szu-Chia
    Lin, Yi-Ching
    Chen, Po-Chih
    Chung, Wei-Shiuan
    Huang, Ya-Chin
    Wu, Ping-Hsun
    Tsai, Yi-Chun
    Huang, Jiun-Chi
    Chiu, Yi-Wen
    Chang, Jer-Ming
    FRONTIERS IN MEDICINE, 2022, 9
  • [35] Association of modifiable metabolic risk factors and lifestyle with all-cause mortality in patients with hepatocellular carcinoma
    Kim, Hwi Young
    Lee, Hye Ah
    Radu, Pompilia
    Dufour, Jean-Francois
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [36] DASC-21 score and risk of rehospitalization and all-cause mortality after discharge in older patients with heart failure
    Shimizu, Ruri
    Ishikawa, Joji
    Jyubishi, Chihiro
    Toba, Ayumi
    Futami, Shutaro
    Morozumi, Ai
    Saito, Yoshihiro
    Komatsu, Shunsuke
    Fujimoto, Hajime
    Ishiyama, Taizo
    Usui, Shinichi
    Tuboko, Yusuke
    Awata, Shuichi
    Akishita, Masahiro
    Harada, Kazumasa
    GERIATRICS & GERONTOLOGY INTERNATIONAL, 2024, 24 (11) : 1130 - 1136
  • [37] The role of variability in night-time mean heart rate on the prediction of ventricular arrhythmias and all-cause mortality in implantable cardioverter defibrillator patients
    Zhao, Shuang
    Chen, Keping
    Su, Yangang
    Hua, Wei
    Pu, Jielin
    Li, Hui
    Dai, Yan
    Tang, Min
    Fan, Xiaohan
    Zhao, Yunzi
    Zheng, Xiaolin
    Cai, Chi
    Li, Zeyi
    Zhang, Shu
    EUROPACE, 2015, 17 : 76 - 82
  • [38] Chronic kidney disease: an independent risk factor of all-cause mortality for elderly Chinese patients with chronic heart failure
    Fu, Shi-Hui
    Zhu, Bing
    Zhang, Yu-Xiao
    Yi, Shuang-Yan
    Liu, Yuan
    Xiao, Tie-Hui
    Wang, Liang
    Bai, Yong-Yi
    Lu, Cai-Yi
    Ye, Ping
    Luo, Lei-Ming
    JOURNAL OF GERIATRIC CARDIOLOGY, 2012, 9 (04) : 355 - 360
  • [39] β-blockers and risk of all-cause mortality in patients with chronic heart failure and atrial fibrillation-a meta-analysis
    Xu, Tianyu
    Huang, Yuli
    Zhou, Haobin
    Bai, Yujia
    Huang, Xingfu
    Hu, Yunzhao
    Xu, Dingli
    Zhang, Yuhui
    Zhang, Jian
    BMC CARDIOVASCULAR DISORDERS, 2019, 19 (1)
  • [40] Combined effect of visit-to-visit variations in heart rate and systolic blood pressure on all-cause mortality in hypertensive patients
    MaoXiang Zhao
    Siyu Yao
    Yao LI
    Miao Wang
    Chi Wang
    Cuijuan Yun
    Sijin Zhang
    Yizhen Sun
    Ziwei Hou
    Shouling Wu
    Hao Xue
    Hypertension Research, 2021, 44 : 1291 - 1299